These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1395074)

  • 21. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
    Josefsberg Z; Ross SA; Lev-Ran A; Hwang DL
    Diabetes Care; 1995 May; 18(5):690-3. PubMed ID: 8586009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.
    Ajayi AA; Campbell BC; Howie CA; Reid JL
    J Hypertens; 1985 Feb; 3(1):47-53. PubMed ID: 2987341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension.
    Paran E; Neumann L; Cristal N; Lowenthal DT
    Am J Cardiol; 1991 Nov; 68(13):1362-6. PubMed ID: 1683148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Converting enzyme inhibition and the common carotid circulation in older patients with sustained essential hypertension.
    Safar M; Asmar R; Bouthier J; Lacolley P; Laurent S
    Eur Heart J; 1988 Mar; 9 Suppl D():75-8. PubMed ID: 2967755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
    Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
    BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of lisinopril and nitrendipine on the pulsatility index in mild essential arterial hypertension.
    Duprez D; De Buyzere M; Brusselmans F; Maas A; Clement DL
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):399-402. PubMed ID: 1325831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of enalapril on the cardiovascular response to treadmill exercise in patients with mild to moderate systemic hypertension.
    Yamauchi K; Furui H; Iwase M; Kamihara S; Hayashi H
    Clin Ther; 1989; 11(6):755-61. PubMed ID: 2558797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical exercise improves cardiac autonomic modulation in hypertensive patients independently of angiotensin-converting enzyme inhibitor treatment.
    Cozza IC; Di Sacco TH; Mazon JH; Salgado MC; Dutra SG; Cesarino EJ; Souza HC
    Hypertens Res; 2012 Jan; 35(1):82-7. PubMed ID: 21956728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner HR; Burnier M
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
    Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
    Ruff D; Gazdick LP; Berman R; Goldberg AI; Sweet CS
    J Hypertens; 1996 Feb; 14(2):263-70. PubMed ID: 8728306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized, comparative study of nitrendipine and enalapril in elderly hypertensive patients.
    Poncelet P; Werquin S; Warembourg A; Ansquer JC; Boussac I; Lekieffre J; Carre A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S67-70. PubMed ID: 1723461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.